$IVOB Could Be Sexy Down Under
December 30th, 2009 at 11:01 am Posted by
From many conversations with his Honors Students and other members of the CollegeStock Community, The Dean knows that many people are waiting patiently and watching $IVOB. So The Dean would also think that those same studious pupils would’ve noticed $IVOB‘s 18% jump yesterday. The Dean believes this is an indication that his valuable lessons, such as how to prepare for huge penny stock profits in 2010, are in fact getting through to his students.
The Dean has been consistently excited about INVO Bioscience (OTC: IVOB.OB) and their low-cost IVF alternative and 2010 could certainly be a big year for the company. Besides the fact that $IVOB is expecting millions in financing over the next couple of years, the company’s CE Mark approved INVOcell device could become extremely attractive for millions of infertile couples worldwide.
Over the past few months, The Dena has taught the student body why he thinks $IVOB Could Become a Crown Favorite in the UK and other countries where government funding and heatlhcare refunds for IVF are available.
News from Queensland, Australia this morning reveals a number of new laws, regulations and changes in benefits, such as funding for IVF, in the upcoming year.
Previously, the Australian government gave couples $5,500 for IVF procedures, estimated to cost $7,000 per cycle there. Today’s news reports that this refund amount will decrease 25% to $4,100, leaving already conflicted couples without an affordable IVF treatment to fulfill their dreams of baby-steps in 2010.
Not only does The Dean believe $IVOB‘s INVO procedure is attractive in countries, like Australia, where IVF funding is available, but even more so in countries with reduced or non-existent government programs for infertile couples.
As 2010 is almost here, The Dean wants to remind the entire student body that $IVOB is an Ivy League Stock Pick—a gift that keeps on giving.
